EMA seeks to revise guidelines on first-in-human clinical trials

The European Medicines Agency (EMA), along with the European Commission and the Member States of the European Union (EU), has proposed changes in guidelines for first-in-human clinical trials.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news